At 3years postprimary vaccination , 64 % , 82 % , and 65 % of subjects initially vaccinated with MenACWY-CRM ( n = 367 ) showed hSBA titers 8 against serogroups C , W-135 , and Y , respectively ; this was lower for serogroup A ( 28 % ) .